Invention Grant
- Patent Title: Combination therapy for the treatment of HCV infection
- Patent Title (中): 联合治疗HCV感染治疗
-
Application No.: US12598802Application Date: 2008-05-05
-
Publication No.: US08258116B2Publication Date: 2012-09-04
- Inventor: Ann Kwong , Nagraj Mani , Yi Zhou , Chao Lin
- Applicant: Ann Kwong , Nagraj Mani , Yi Zhou , Chao Lin
- Applicant Address: US MA Cambridge
- Assignee: Vertex Pharmaceuticals Incorporated
- Current Assignee: Vertex Pharmaceuticals Incorporated
- Current Assignee Address: US MA Cambridge
- Agency: Honigman Miller Schwartz and Cohn LLP
- Agent Noel E. Day; Jonathan P. O'Brien
- International Application: PCT/US2008/005758 WO 20080505
- International Announcement: WO2008/137126 WO 20081113
- Main IPC: A01N43/04
- IPC: A01N43/04 ; A61K31/70
Abstract:
The present invention relates to therapeutic combinations comprising a protease inhibitor and a polymerase inhibitor for the treatment of HCV. The present invention also relates to therapeutic combinations comprising VX-950 and a polymerase inhibitor. Also within the scope of the invention are methods using the therapeutic combinations of the present invention for treating HCV infection or alleviating one or more symptoms thereof in a patient. The present invention also provides kits comprising the combinations of the present invention.
Public/Granted literature
- US20100172866A1 Combination Therapy for the Treatment of HCV Infection Public/Granted day:2010-07-08
Information query
IPC分类:
